Teva returns to roots after 'nuthouse' board ousts CEO

Bloomberg Businessweek

This time last year, the chairman and chief executive officer of Israel's Teva Pharmaceutical Industries, the world's biggest generic drugmaker, were foreigners. Now, Teva's brief experiment with outside leadership is ending

Letter
to the
Editor

Send us a letter

Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

Recommended for You
U.S. Food and Drug Administration (FDA)
Upcoming FDA draft on pulse oximetry's racial bias draws questions
Most Popular
1
'We share some of the responsibility,' UnitedHealth CEO writes
2
Salesforce, Epic and the rise of CRM programs
3
OptumHealth backs out of 'dummy code' lawsuit settlement
4
Josh Hawley slams PCMA using Brian Thompson's death as a 'shield'
5
Supreme Court's silence fortifies 340B contract pharmacy laws